If You Invested $10,000 in Novo Nordisk in 2018, This Is How Much You Would Have Today
Pharmaceutical companies with robust drug portfolios and pipelines can generate substantial wealth for investors over time. That's because they have the vital ingredients necessary to power revenue and profits higher: needed products that help patients. And this translates into capital appreciation.
Few companies better exemplify this pattern than Danish pharmaceutical giant Novo Nordisk (NYSE: NVO). In just five years, the company has turned a $10,000 investment into $39,000, including reinvested dividends. By comparison, the same amount invested in the S&P 500 would now be worth just $17,000 with dividends reinvested.
For an idea of what drove these sizzling returns -- and what could lay ahead -- let's examine Novo Nordisk's fundamentals.
Source Fool.com
